Expert consensus on pulpotomy in the management of mature permanent teeth with pulpitis

Abstract

Pulpotomy, which belongs to vital pulp therapy, has become a strategy for managing pulpitis in recent decades. This minimally invasive treatment reflects the recognition of preserving healthy dental pulp and optimizing long-term patient-centered outcomes. Pulpotomy is categorized into partial pulpotomy (PP), the removal of a partial segment of the coronal pulp tissue, and full pulpotomy (FP), the removal of whole coronal pulp, which is followed by applying the biomaterials onto the remaining pulp tissue and ultimately restoring the tooth. Procedural decisions for the amount of pulp tissue removal or retention depend on the diagnostic of pulp vitality, the overall treatment plan, the patient’s general health status, and pulp inflammation reassessment during operation. This statement represents the consensus of an expert committee convened by the Society of Cariology and Endodontics, Chinese Stomatological Association. It addresses the current evidence to support the application of pulpotomy as a potential alternative to root canal treatment (RCT) on mature permanent teeth with pulpitis from a biological basis, the development of capping biomaterial, and the diagnostic considerations to evidence-based medicine. This expert statement intends to provide a clinical protocol of pulpotomy, which facilitates practitioners in choosing the optimal procedure and increasing their confidence in this rapidly evolving field.

References

[1] Barani M, Aliu X, Ajeti N, Asllani L. Assessment of correlation between clinical, radiographic, microbiological, and histopathological examinations in identification of pulpal diseases—a single-centre study Saudi. Dent. J., 2023, 35: 540-546.

[2] Hashem D, et al.. Clinical and radiographic assessment of the efficacy of calcium silicate indirect pulp capping: a randomized controlled clinical trial J. Dent. Res., 2015, 94: 562-568.

[3] Ge L, Ling J. Prevalence of pulpal disease and risk indicators analysis in Guangzhou Chin. J. Stomatol. Res., 2009, 3: 71-77

[4] Yue L, Wang J. Evaluation of therapeutic concept and methods for infected pulp Zhonghua. Kou. Qiang. Yi. Xue. Za. Zhi., 2002, 37: 324-326

[5] Hargreaves, K. M. & Cohen, S. (eds.) Cohen’s Pathways of the Pulp 10th edn (2010).

[6] Wang, M. The theory and practice of resinifying therapy. Beijing. Da. Xue. Xue. Bao. Yi. Xue. Ban. 51, 144–150 (1964).

[7] Soderberg T. Pulp mummification Am. J. Dent. Sci., 1899, 33: 145-149

[8] Wang M, Lin Q. A clinical study of resinifying therapy in infected dental pulp Zhonghua. Kou. Qiang. Ke. Za. Zhi., 1979, 14: 30-32

[9] Gulabivala K, Ng YL. Factors that affect the outcomes of root canal treatment and retreatment—a reframing of the principles Int. Endod. J., 2023, 56: 82-115.

[10] León-López M, et al.. Prevalence of root canal treatment worldwide: a systematic review and meta-analysis Int. Endod. J., 2022, 55: 1105-1127.

[11] Torres A, Boelen GJ, Lambrechts P, Pedano MS, Jacobs R. Dynamic navigation: a laboratory study on the accuracy and potential use of guided root canal treatment Int. Endod. J., 2021, 54: 1659-1667.

[12] American Association of Endodontists. Glossary Of Endodontic Terms 10th edn (AAE, 2020).

[13] Duncan HF. Present status and future directions—vital pulp treatment and pulp preservation strategies Int. Endod. J., 2022, 55: 497-511.

[14] Morotomi T, Washio A, Kitamura C. Current and future options for dental pulp therapy Jpn. Dent. Sci. Rev., 2019, 55: 5-11.

[15] Bogen, G., Dammaschke, T. & Chandler, N. in Vital Pulp Therapy in Pathways of the Pulp (eds Berman, L. & Hargreaves, K. M.) Ch 26 (Elsevier, 2021).

[16] Alfaisal Y, et al.. Vital pulp therapy-factors influencing decision-making for permanent mature teeth with irreversible pulpitis: a systematic review Int. Endod. J., 2024, 57: 505-519.

[17] Schmalz G, Widbiller M, Galler KM. Clinical perspectives of pulp regeneration J. Endod., 2020, 46: S161-s174.

[18] Duncan HF, et al.. European Society of Endodontology position statement: Management of deep caries and the exposed pulp Int. Endod. J., 2019, 52: 923-934.

[19] Philip N, Suneja B. Minimally invasive endodontics: a new era for pulpotomy in mature permanent teeth Br. Dent. J., 2022, 233: 1035-1041.

[20] AAE. Position statement on vital pulp therapy. J. Endod. 47, 1340–1344 (2021).

[21] Cvek M. A clinical report on partial pulpotomy and capping with calcium hydroxide in permanent incisors with complicated crown fracture J. Endod., 1978, 4: 232-237.

[22] Mejàre I, Cvek M. Partial pulpotomy in young permanent teeth with deep carious lesions Endod. Dent. Traumatol., 1993, 9: 238-242.

[23] Lin LM, Ricucci D, Saoud TM, Sigurdsson A, Kahler B. Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology Aust. Endod. J., 2020, 46: 154-166.

[24] Li Y, et al.. Efficacy of pulpotomy in managing irreversible pulpitis in mature permanent teeth: a systematic review and meta-analysis J. Dent., 2024, 144: 104923.

[25] Taha NA, Abuzaid AM, Khader YS. A randomized controlled clinical trial of pulpotomy versus root canal therapy in mature teeth with irreversible pulpitis: outcome, quality of life, and patients’ satisfaction J. Endod., 2023, 49: 624-631.e622.

[26] Galler KM, Weber M, Korkmaz Y, Widbiller M, Feuerer M. Inflammatory response mechanisms of the dentine-pulp complex and the periapical tissues Int. J. Mol. Sci., 2021, 22: 1480.

[27] Erdogan O, Xia J, Chiu IM, Gibbs JL. Dynamics of innate immune response in bacteria-induced mouse model of pulpitis J. Endod., 2023, S0099-2399: 00539-3

[28] He H, Hao Y, Fan Y, Li B, Cheng L. The interaction between innate immunity and oral microbiota in oral diseases Expert. Rev. Clin. Immunol., 2023, 19: 405-415.

[29] Wang J, et al.. Identification of the characteristics of infiltrating immune cells in pulpitis and its potential molecular regulation mechanism by bioinformatics method Bmc. Oral. Health, 2023, 23. 287

[30] Farges JC, et al.. Dental pulp defence and repair mechanisms in dental caries Mediators. Inflamm., 2015, 2015: 230251.

[31] Duncan HF, Cooper PR. Pulp innate immune defense: translational opportunities J. Endod., 2020, 46: S10-s18.

[32] Ji X, Zhang L, Yang F, Huang DM. Innate immune sensing of nucleic acid in endodontic infection Int. Endod. J., 2022, 55: 1335-1346.

[33] He W, Yu Q. New advances in vital pulp therapy and pulp regeneration for the treatment of pulpitis: from basic to clinical application Zhonghua. Kou. Qiang. Yi. Xue. Za. Zhi., 2022, 57: 16-22

[34] Zhou L, et al.. Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway Cell. Commun. Signal., 2021, 19. 58

[35] Farges JC, et al.. Odontoblasts in the dental pulp immune response J. Exp. Zool. B. Mol. Dev. Evol., 2009, 312b: 425-436.

[36] Contreras C, Cádiz B, Schmachtenberg O. Determination of the severity of pulpitis by immunohistological analysis and comparison with the clinical picture J. Endod., 2023, 49: 26-35.

[37] Donnermeyer D, Dammaschke T, Lipski M, Schäfer E. Effectiveness of diagnosing pulpitis: a systematic review Int. Endod. J., 2023, 56: 296-325.

[38] Huang X, Liu F, Hou J, Chen K. Inflammation-induced overexpression of microRNA-223-3p regulates odontoblastic differentiation of human dental pulp stem cells by targeting SMAD3 Int. Endod. J., 2019, 52: 491-503.

[39] Jontell M, Bergenholtz G. Accessory cells in the immune defense of the dental pulp Proc. Finn. Dent. Soc., 1992, 88: 344-355

[40] Zhang J, et al.. The existence of CD11c+ sentinel and F4/80+ interstitial dendritic cells in dental pulp and their dynamics and functional properties Int. Immunol., 2006, 18: 1375-1384.

[41] Brignardello-Petersen R. Mineral trioxide aggregate may be superior to calcium hydroxide for histologic dentin bridge formation after pulp capping J. Am. Dent. Assoc., 2019, 150: e29.

[42] Hilton TJ. Keys to clinical success with pulp capping: a review of the literature Oper. Dent., 2009, 34: 615-625.

[43] Andelin WE, Shabahang S, Wright K, Torabinejad M. Identification of hard tissue after experimental pulp capping using dentin sialoprotein (DSP) as a marker J. Endod., 2003, 29: 646-650.

[44] Ricucci D, Rôças IN, Alves FRF, Cabello PH, Siqueira JF Jr.. Outcome of direct pulp capping using calcium hydroxide: a long-term retrospective study J. Endod., 2023, 49: 45-54.

[45] Li Z, Cao L, Fan M, Xu Q. Direct pulp capping with calcium hydroxide or mineral trioxide aggregate: a meta-analysis J. Endod., 2015, 41: 1412-1417.

[46] Sarkar NK, Caicedo R, Ritwik P, Moiseyeva R, Kawashima I. Physicochemical basis of the biologic properties of mineral trioxide aggregate J. Endod., 2005, 31: 97-100.

[47] Tzanetakis GN, Papanakou S, Koletsi D, Georgopoulou M. Outcome of partial pulpotomy in immature permanent teeth with symptomatic irreversible pulpitis: a prospective case series assessment J. Endod., 2023, 49: 1120-1128.

[48] Jung JY, et al.. Effect of biodentine and bioaggregate on odontoblastic differentiation via mitogen-activated protein kinase pathway in human dental pulp cells Int. Endod. J., 2015, 48: 177-184.

[49] Sinkar RC, Patil SS, Jogad NP, Gade VJ. Comparison of sealing ability of ProRoot MTA, RetroMTA, and Biodentine as furcation repair materials: an ultraviolet spectrophotometric analysis J. Conserv. Dent., 2015, 18: 445-448.

[50] Makhlouf M, et al.. Sealing ability of calcium silicate-based materials in the repair of furcal perforations: a laboratory comparative study J. Contemp. Dent. Pract., 2020, 21: 1091-1097

[51] Cushley S, et al.. Efficacy of direct pulp capping for management of cariously exposed pulps in permanent teeth: a systematic review and meta-analysis Int. Endod. J., 2021, 54: 556-571.

[52] Alsalleeh F, Chung N, Stephenson L. Antifungal activity of endosequence root repair material and mineral trioxide aggregate J. Endod., 2014, 40: 1815-1819.

[53] Liu M, He L, Wang H, Su W, Li H. Comparison of in vitro biocompatibility and antibacterial activity of two calcium silicate-based materials J. Mater. Sci. Mater. Med., 2021, 32: 52.

[54] Hu X, Liang Z, Wang Q, Liu L. A retrospective study of iRoot BP Plus pulpotomy compared with Vitapex pulpectomy for irreversible pulpitis of primary molars with the presence of coronal pulp tissue Int. J. Paediatr. Dent., 2023, 33: 216-226.

[55] Zeng Q, et al.. Concentrated growth factor combined with iRoot BP Plus promotes inflamed pulp repair: an in vitro and in vivo study Bmc. Oral. Health, 2023, 23. 225

[56] Rao Q, et al.. Comparison of iRoot BP plus and calcium hydroxide as pulpotomy materials in permanent incisors with complicated crown fractures: a retrospective study J. Endod., 2020, 46: 352-357.

[57] Zhou X, et al.. Vital pulp therapy of damaged dental pulp Hua. Xi. Kou. Qiang. Yi. Xue. Za. Zhi., 2017, 35: 339-347

[58] Ricucci D, Siqueira JF Jr., Li Y, Tay FR. Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure J. Dent., 2019, 86: 41-52.

[59] Wolters WJ, et al.. Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs Int. Endod. J., 2017, 50: 825-829.

[60] Careddu R, Duncan HF. A prospective clinical study investigating the effectiveness of partial pulpotomy after relating preoperative symptoms to a new and established classification of pulpitis Int. Endod. J., 2021, 54: 2156-2172.

[61] Alqaderi H, Lee CT, Borzangy S, Pagonis TC. Coronal pulpotomy for cariously exposed permanent posterior teeth with closed apices: a systematic review and meta-analysis J. Dent., 2016, 44: 1-7.

[62] Li Y, et al.. Pulpotomy for carious pulp exposures in permanent teeth: a systematic review and meta-analysis J. Dent., 2019, 84: 1-8.

[63] Cushley S, et al.. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: a systematic review J. Dent., 2019, 88: 103158.

[64] Elmsmari F, et al.. Outcome of partial pulpotomy in cariously exposed posterior permanent teeth: a systematic review and meta-analysis J. Endod., 2019, 45: 1296-1306.e1293.

[65] Zafar K, Nazeer MR, Ghafoor R, Khan FR. Success of pulpotomy in mature permanent teeth with irreversible pulpitis: a systematic review J. Conserv. Dent., 2020, 23: 121-125.

[66] Lin GSS, et al.. Success rates of coronal and partial pulpotomies in mature permanent molars: a systematic review and single-arm meta-analysis Quintessence Int., 2021, 52: 196-208

[67] Leong DJX, Yap AU. Vital pulp therapy in carious pulp-exposed permanent teeth: an umbrella review Clin. Oral. Investig., 2021, 25: 6743-6756.

[68] Santos JM, Pereira JF, Marques A, Sequeira DB, Friedman S. Vital pulp therapy in permanent mature posterior teeth with symptomatic irreversible pulpitis: a systematic review of treatment outcomes Medicina, 2021, 57: 573.

[69] Albaiti SS, et al.. Partial pulpotomy as an applicable treatment option for cariously exposed posterior permanent teeth: a systematic review of randomized clinical trials Cureus, 2022, 14 e26573

[70] Ather A, Patel B, Gelfond JAL, Ruparel NB. Outcome of pulpotomy in permanent teeth with irreversible pulpitis: a systematic review and meta-analysis Sci. Rep., 2022, 12. 19664

[71] Skitioui M, Seck A, Niang SO, Fikhar A, Touré B. The treatment of mature permanent teeth with irreversible pulpitis by cervical pulpotomy: a systematic review Aust. Endod. J., 2023, 49: 488-493.

[72] Tomson PL, et al.. Effectiveness of pulpotomy compared with root canal treatment in managing non-traumatic pulpitis associated with spontaneous pain: a systematic review and meta-analysis Int. Endod. J., 2023, 56: 355-369.

[73] Zou X, et al.. Expert consensus on irrigation and intracanal medication in root canal therapy Int. J. Oral. Sci., 2024, 16: 23.

[74] Mainkar A, Kim SG. Diagnostic accuracy of 5 dental pulp tests: a systematic review and meta-analysis J. Endod., 2018, 44: 694-702.

[75] Abd-Elmeguid A, Yu DC. Dental pulp neurophysiology: part 2. Current diagnostic tests to assess pulp vitality J. Can. Dent. Assoc., 2009, 75: 139-143

[76] Baranwal HC, Mittal N, Yadav J, Rani P, Naveen Kumar PG. Outcome of partial pulpotomy verses full pulpotomy using biodentine in vital mature permanent molar with clinical symptoms indicative of irreversible pulpitis: a randomized clinical trial J. Conserv. Dent., 2022, 25: 317-323

[77] Ramani A, et al.. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: a randomized clinical trial Int. Endod. J., 2022, 55: 430-440.

[78] Jassal A, et al.. Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: a randomized controlled trial Int. Endod. J., 2023, 56: 331-344.

[79] Alghaithy RA, Qualtrough AJ. Pulp sensibility and vitality tests for diagnosing pulpal health in permanent teeth: a critical review Int. Endod. J., 2017, 50: 135-142.

[80] Mohammadi Z. Sodium hypochlorite in endodontics: an update review Int. Dent. J., 2008, 58: 329-341.

[81] Witherspoon DE. Vital pulp therapy with new materials: new directions and treatment perspectives—permanent teeth J. Endod., 2008, 34: S25-S28.

[82] Aguilar P, Linsuwanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: a systematic review J. Endod., 2011, 37: 581-587.

[83] Nair PN, Duncan HF, Pitt Ford TR, Luder HU. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial Int. Endod. J., 2008, 41: 128-150.

[84] Liu S, Wang S, Dong Y. Evaluation of a bioceramic as a pulp capping agent in vitro and in vivo J. Endod., 2015, 41: 652-657.

[85] Atmeh AR, Chong EZ, Richard G, Festy F, Watson TF. Dentin-cement interfacial interaction: calcium silicates and polyalkenoates J. Dent. Res., 2012, 91: 454-459.

[86] Linsuwanont P, Wimonsutthikul K, Pothimoke U, Santiwong B. Treatment outcomes of mineral trioxide aggregate pulpotomy in vital permanent teeth with carious pulp exposure: the retrospective study J. Endod., 2017, 43: 225-230.

[87] Qudeimat MA, Alyahya A, Hasan AA. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study Int. Endod. J., 2017, 50: 126-134.

[88] Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial J. Endod., 2017, 43: 1417-1421.

[89] Uesrichai N, et al.. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial Int. Endod. J., 2019, 52: 749-759.

[90] Asgary S, Eghbal MJ, Bagheban AA. Long-term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: a multi-center randomized controlled trial Am. J. Dent., 2017, 30: 151-155

[91] Taha NA, Al-Rawash MH, Imran ZA. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate-based materials: a parallel, double blind, randomized controlled trial Int. Endod. J., 2022, 55: 416-429.

[92] Tuna D, Olmez A. Clinical long-term evaluation of MTA as a direct pulp capping material in primary teeth Int. Endod. J., 2008, 41: 273-278.

[93] Coll JA, et al.. Primary tooth vital pulp therapy: a systematic review and meta-analysis Pediatr. Dent., 2017, 39: 16-123

[94] Duncan HF, El-Karim I, Dummer PMH, Whitworth J, Nagendrababu V. Factors that influence the outcome of pulpotomy in permanent teeth Int. Endod. J., 2023, 56: 62-81.

[95] Bakhtiar H, et al.. Human pulp responses to partial pulpotomy treatment with TheraCal as compared with biodentine and ProRoot MTA: a clinical trial J. Endod., 2017, 43: 1786-1791.

[96] Azimi S, et al.. Comparison of pulp response to mineral trioxide aggregate and a bioceramic paste in partial pulpotomy of sound human premolars: a randomized controlled trial Int. Endod. J., 2014, 47: 873-881.

[97] Caldeira CL, Barletta FB, Ilha MC, Abrão CV, Gavini G. Pulse oximetry: a useful test for evaluating pulp vitality in traumatized teeth Dent. Traumatol., 2016, 32: 385-389.

[98] Sabeti MA, Nikghalb KD, Pakzad R, Fouad AF. Expression of selected inflammatory mediators with different clinical characteristics of pulpal inflammation J. Endod., 2024, 50: 336-343.

[99] Karrar RN, et al.. Molecular biomarkers for objective assessment of symptomatic pulpitis: a systematic review and meta-analysis Int. Endod. J., 2023, 56: 1160-1177.

[100] Chen M, Zeng J, Yang Y, Wu B. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets Bmc. Oral. Health, 2020, 20. 279

[101] Richert R, et al.. A critical analysis of research methods and experimental models to study pulpitis Int. Endod. J., 2022, 55: 14-36.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82071110)

RIGHTS & PERMISSIONS

The Author(s)